Month: December 2025

news_6

Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies

BANGALORE, India--(BUSINESS WIRE)--#AurigeneOncology--Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, today announced initial clinical results from...

news_6

Trends & Strategies Shaping the $2.22 Billion Smart Syringes Market, 2025-2033 – Government-Led Immunization Initiatives Propel Uptake of Auto-Disable Smart Syringes – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Smart Syringes Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global smart syringes market is...